i agree with the addition to the board, make sense,(a corporate update) as Novartis would want a say, and protect their interests,
I had posed the question whether there were milestones payments around yesterday results, even thought is was secondary endpoint- and/or MSB gets approval with 60% mortality rate, which was the real endpoint that the FDA advised they were interested in seeing on the way to approval?
would Novartis upgrade there agreement in such a short time? only reason i could see if, Novartis believe their own pipelines etc don't have the potential as MSB, or even in combined use? ,
it could as sort of cheap buyin from Novartis rather than a TO, with a injection in part.
i agree with the addition to the board, make sense,(a corporate...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
-0.020(2.01%) |
Mkt cap ! $1.124B | |||
| Open | High | Low | Value | Volume |
| $1.00 | $1.01 | 97.5¢ | $739.1K | 749.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 70340 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 98.0¢ | 55835 | 25 |
View Market Depth
| Last trade - 12.08pm 20/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |